Search Results
MRD detection rates with a personalized and a tumor-informed ctDNA assay in patients with stage ...
Advances in testing: A personalized, ctDNA assay for MRD detection and surveillance
Incorporating a Personalized, Tumor-informed ctDNA Monitoring Assay in Clinical Practice
ARTEMIS-PC: personalized panel for circulating tumor DNA in pancreatic cancer
ctDNA and MRD Testing | Colorectal Cancer Care Tools for Surveillance
A ctDNA assay for remote monitoring and risk stratification
Cancer treatment and tumor-informed residual disease testing
ctDNA and MRD: Who, When, and Then What? | 2022 Evolution Conference
Informed by the tumor: The power of a personalized ctDNA Assay for Treatment Monitoring in HER2
Dr Pusztai on Molecular Residual Disease Monitoring in Early Breast Cancer
Deep Dive Into the Utility of Personalized MRD Monitoring -- 2020 ASCO Recap
Postsurgical Disease Recurrence in Stage I to III Colorectal Cancer May Be Predicted by ctDNA
